Online TP (Training Program) on SC (Social Cognition) for Schizophrenia (TP;SC)

June 1, 2023 updated by: Francisco Pulido, University of La Laguna

Online Training Program on Social Cognition for Patients With Schizophrenia

Randomized controlled trial. Sixty-five participants (83% with schizophrenia or bipolar disorder) were recruited from community mental health teams. Fifty-seven met criteria and agreed to participate in the study. The conditions of cognitive rehabilitation were assigned randomly with support employment CR + IPS (n = 28) and IPS alone (n = 29). Cogpack program was used. Two groups were followed at 8 and 12 months after the baseline.

Study Overview

Detailed Description

This work was developed in the island of Tenerife (Spain) within a public service specialised in labour integration of people with disabilities in which an IPS team was set up in 2005. The study was carried out in collaboration with the units of community mental health of the island. These units carry out the control of people with serious mental illnesses including pharmacological treatment and psychosocial programming. All research procedures were approved by the Medicine Committee of Canary Health Services.

The follow-up period for the data collection was set between 2013 and 2014. Employment specialists belong to a public institution specialized in work disability.Sixty-five participants but only 57 signed written informed consent and completed the baseline. Two groups were assigned randomly:one with support employment and cognitive rehabilitation the second group with IPS alone

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Santa CRUZ DE Tenerife
      • La Laguna, Santa CRUZ DE Tenerife, Spain, 38205
        • Francisco Rodriguez Pulido

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Participants had to:

  1. comply with the state definitions of severe mental illness (SMI), which includes an ICD-10 (World Health Organization, 1992) diagnosis of F20- 29 (schizophrenia, schizotypal, delusional and other non-mood psychotic disorders) and F31-F32.3 (major mood affective disorders)
  2. have previous difficulties to maintain a job
  3. currently want a competitive job and
  4. accept the job search starts

Exclusion Criteria:

People with no Severe mental illness and not want to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Experimental Group (e-Motional Training and Individual Placement and Support)
Cognitive Rehabilitation and Individual Placement and Support
Other Names:
  • CR and IPS
No Intervention: Control
Control Group (Individual Placement and Support)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ekman 60 Faces Test total score changes
Time Frame: At baseline and after 1 year treatment
Minimum 0 and maximum 60. Between 20-40 years average 51.43, cut-off point 45, below deficit. Between 40-60 years, average 51.20, cut-off point 43, below deficit.
At baseline and after 1 year treatment
Hinting Task total score changes
Time Frame: At baseline and after 1 year treatment
Total 1 minimum 0 and maximum 20. Total 2 minimum 0 and maximum 10. Cut-off point 18, less deficit.
At baseline and after 1 year treatment
Happé Strange Stories Test total score changes
Time Frame: At baseline and after 1 year treatment
Total control minimum 0 and maximum 16. Total theory of mind minimum 0 and maximum 16. Cut-off point 14, below the deficit.
At baseline and after 1 year treatment
Faux Pas Recognition Test total score changes
Time Frame: At baseline and after 1 year treatment
FP stories and C questions, C stories and FP questions and C stories and C questions minimum 0 and maximum 20. FP stories and FP questions minimum 0 and maximum 60. Cut-off point without errors 54 and with errors 48, lower deficit scores.
At baseline and after 1 year treatment
Ambiguous Intentions and Hostility Questionnaire total score changes
Time Frame: At baseline and after 1 year treatment
Hostility, anger, guilt and aggression minimum 1 and maximum 5. Intentionality minimum 1 and maximum 6. Calculate the mean.
At baseline and after 1 year treatment
Movie for the Assessment of Social Cognition total score changes
Time Frame: At baseline and after 1 year treatment
Minimum 0 and maximum 42.
At baseline and after 1 year treatment
Screening for Cognitive Impairment in Psychiatry (SCIP-S) total score changes
Time Frame: At baseline and after 1 year treatment
Minimum 1 and maximum 99, very low range 1-2.5 and low range 2.5-15. The deterioration depends on the scale.
At baseline and after 1 year treatment
Positive and Negative Symptom Scale (PANSS) total score changes
Time Frame: At baseline and after 1 year treatment
Positive and negative subscales minimum 7 and maximum 49. General psychopathology subscale minimum 16 and maximum 112. Composite subscale minimum -42 and maximum +42. Categorize subtype positive >0 and negative <0.
At baseline and after 1 year treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Employment
Time Frame: Up to 12 months in 2021
Number of jobs
Up to 12 months in 2021

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Francisco Rodriguez Pulido, PHD MD, University of La Laguna

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 13, 2019

Primary Completion (Actual)

October 18, 2021

Study Completion (Actual)

January 10, 2022

Study Registration Dates

First Submitted

September 11, 2019

First Submitted That Met QC Criteria

May 9, 2023

First Posted (Actual)

May 19, 2023

Study Record Updates

Last Update Posted (Actual)

June 6, 2023

Last Update Submitted That Met QC Criteria

June 1, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Publicate the results in a International Journal

IPD Sharing Time Frame

2019-2020

IPD Sharing Access Criteria

International Journal

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Social Cognition

Clinical Trials on Cognitive Rehabilitation and Individual Placement and Support

3
Subscribe